hydroxychloroquine has been researched along with buparlisib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ju, W; Kim, CY; Kim, HJ; Kim, SC; Kim, YH; Lee, SY | 1 |
Chen, ZS; Claret, FX; Elkabets, M; Jiao, W; Kong, D; Peng, X; Wang, F; Wang, R; Yang, Y; Zhang, S; Zhong, Y; Zhong, Z | 1 |
2 other study(ies) available for hydroxychloroquine and buparlisib
Article | Year |
---|---|
Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
Topics: 14-3-3 Proteins; Active Transport, Cell Nucleus; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Biomarkers, Tumor; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Cytoplasm; Dose-Response Relationship, Drug; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hydroxychloroquine; Morpholines; Mutation; Protein Kinase Inhibitors; RNA Interference; Signal Transduction; Time Factors; Transfection; Uterine Cervical Neoplasms | 2017 |
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
Topics: Aminopyridines; Animals; Autophagy; Humans; Hydroxychloroquine; Mice; Mice, Nude; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Zebrafish | 2021 |